CoNetrix Named a Top Small Business for Leadership and Career Growth by Comparably
13-06-2026 05:55 via prnewswire.com

CoNetrix Named a Top Small Business for Leadership and Career Growth by Comparably

LUBBOCK, Texas, June 12, 2026 /PRNewswire/ -- Based on anonymous ratings from current employees over the past 12 months, CoNetrix has received two Comparably awards for 2026. The company was ranked 8th overall among small businesses for Best Leadership Team and also received an award for...
Read more »

PR Public relations news



SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK
SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK
Tradr to Ring Opening Bell at Cboe to Celebrate SpaceX ETF Launches
Tradr to Ring Opening Bell at Cboe to Celebrate SpaceX ETF Launches
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
RiderNav presenta sus pantallas inteligentes de 7 pulgadas para motocicletas en el Mid-Summer Riding Festival
RiderNav presenta sus pantallas inteligentes de 7 pulgadas para motocicletas en el Mid-Summer Riding Festival
AFX accelera l'espansione globale guidata dall'esperto del settore Ken C
AFX accelera l'espansione globale guidata dall'esperto del settore Ken C
AFX beschleunigt globale Expansion mit Branchenveteran Ken C als Leiter für Wachstum
AFX beschleunigt globale Expansion mit Branchenveteran Ken C als Leiter für Wachstum
AFX accélère son expansion mondiale sous la houlette de Ken C pour mener à bien sa croissance
AFX accélère son expansion mondiale sous la houlette de Ken C pour mener à bien sa croissance
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Bitmine Immersion Technologies gibt erste Dividendenausschüttung und Notierung der Vorzugsaktien der Serie A an der NYSE bekannt
Bitmine Immersion Technologies gibt erste Dividendenausschüttung und Notierung der Vorzugsaktien der Serie A an der NYSE bekannt
Bitmine Immersion Technologies annonce les premiers dividendes et la cotation au NYSE de ses actions privilégiées de série A
Bitmine Immersion Technologies annonce les premiers dividendes et la cotation au NYSE de ses actions privilégiées de série A
Bitmine Immersion Technologies kondigt initiële dividenden en een NYSE-notering aan voor Series A Preferred Stock
Bitmine Immersion Technologies kondigt initiële dividenden en een NYSE-notering aan voor Series A Preferred Stock
Bitmine Immersion Technologies annuncia i dividendi iniziali e la quotazione al NYSE di azioni privilegiate di Serie A
Bitmine Immersion Technologies annuncia i dividendi iniziali e la quotazione al NYSE di azioni privilegiate di Serie A
Bitmine: dividendos iniciales y cotización en la Bolsa de Nueva York para acciones preferentes de Serie A
Bitmine: dividendos iniciales y cotización en la Bolsa de Nueva York para acciones preferentes de Serie A
Las estrellas del fútbol que se perdieron la Copa de este verano reciben una invitación de Ecuador
Las estrellas del fútbol que se perdieron la Copa de este verano reciben una invitación de Ecuador
Desktop versie